ReShape Lifesciences Inc.
RSLS
$0.6355
$0.00050.08%
09/30/2024 | 06/30/2024 | ||||
---|---|---|---|---|---|
Revenue | 16.64% | 1.08% | |||
Total Other Revenue | -- | -- | |||
Total Revenue | 16.64% | 1.08% | |||
Cost of Revenue | 2.65% | 6.68% | |||
Gross Profit | 26.90% | -2.66% | |||
SG&A Expenses | 0.43% | -3.53% | |||
Depreciation & Amortization | -- | -- | |||
Other Operating Expenses | -- | -- | |||
Total Operating Expenses | 0.85% | -3.25% | |||
Operating Income | 14.26% | 7.06% | |||
Income Before Tax | 0.32% | 27.49% | |||
Income Tax Expenses | -60.00% | 7.14% | |||
Earnings from Continuing Operations | 0.88% | 27.27% | |||
Earnings from Discontinued Operations | -- | -- | |||
Extraordinary Item & Accounting Change | -- | -- | |||
Minority Interest in Earnings | -- | -- | |||
Net Income | 0.88% | 27.27% | |||
EBIT | 14.26% | 7.06% | |||
EBITDA | 14.26% | 7.08% | |||
EPS Basic | 15.29% | 32.36% | |||
Normalized Basic EPS | 33.00% | 14.25% | |||
EPS Diluted | 15.29% | 32.36% | |||
Normalized Diluted EPS | 33.00% | 14.25% | |||
Average Basic Shares Outstanding | 17.02% | 7.54% | |||
Average Diluted Shares Outstanding | 17.02% | 7.54% | |||
Dividend Per Share | -- | -- | |||
Payout Ratio | -- | -- |